{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:22:09Z","timestamp":1740140529516,"version":"3.37.3"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001203","name":"GlaxoSmithKline Australia Pty Ltd and Bayer Australia Pty Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Phosphodiesterase type 5 inhibitor drugs produce vasodilatation by inhibiting the breakdown of cyclic guanosine monophosphate and have proven efficacy in treating erectile dysfunction (ED).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To evaluate the efficacy, safety, and tolerability of vardenafil in men with moderate to severe ED of broad etiology.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>The erectile function (EF) domain score, the response to Questions 13 and 14 of the International Index of Erectile Function (IIEF) questionnaire, and the proportion of \u201cyes\u201d responses to questions 2 and 3 of the Sexual Encounter Profile (SEP), a Global Assessment (GAQ), and Global Satisfaction Questions (GSQ) were compared at baseline and at 12 weeks of treatment with as-needed vardenafil.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 326 subjects with a mean age of 57.6 years and moderate to severe erectile dysfunction of various etiologies received vardenafil (5\u201320 mg) for 12 weeks in a prospective multicenter, open-label flexible-dose study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with baseline, vardenafil was superior in all efficacy outcomes. A significant mean improvement of 13.4 (P &amp;lt; 0.001) in the EF domain from baseline was obtained at week 12. Subjects who received 5, 10, and 20 mg vardenafil at week 12 experienced improvements of 11.9, 15.1, and 12.9 respectively in the EF domain score. Sexual intercourse was successfully completed (SEP3) in 76.3%, 80.1%, and 74.3% of subjects receiving 5, 10, and 20 mg vardenafil compared with 25.9%, 17.9%, and 19.2% at baseline, respectively. For all doses combined at week 12, the change in SEP3 from baseline was 56.7% (P &amp;lt; 0.001). Treatment with vardenafil was well tolerated, and headaches, flushing, nasal congestion, and dyspepsia were the most frequently observed adverse events.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Vardenafil was effective and well tolerated in men with moderate to severe erectile dysfunction. Treatment with vardenafil was associated with a significantly higher IIEF erectile function domain score and completion of successful intercourse rate compared with baseline.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2006.00296.x","type":"journal-article","created":{"date-parts":[[2006,8,21]],"date-time":"2006-08-21T17:47:47Z","timestamp":1156182467000},"page":"892-900","source":"Crossref","is-referenced-by-count":5,"title":["Vardenafil Improved Erectile Function in a \u201cReal-Life\u201d Broad Population Study of Men with Moderate to Severe Erectile Dysfunction in Australia and New Zealand"],"prefix":"10.1093","volume":"3","author":[{"given":"Chris","family":"McMahon","sequence":"first","affiliation":[{"name":"Australian Centre for Sexual Health , Sydney , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Lording","sequence":"additional","affiliation":[{"name":"Cabrini Hospital , Melbourne , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwyn","family":"Stuckey","sequence":"additional","affiliation":[{"name":"Keogh Institute for Medical Research\u2014Endocrinology and Diabetes , Perth , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ven","family":"Tan","sequence":"additional","affiliation":[{"name":"Hurstville Medical Clinic , Sydney , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gillman","sequence":"additional","affiliation":[{"name":"Health Institute for Men , Brisbane , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warwick","family":"White","sequence":"additional","affiliation":[{"name":"Eastern Men\u2019s Clinic , Auckland , New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Di Natale","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline , Melbourne , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Bramwell","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline , Melbourne , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,9,1]]},"reference":[{"key":"2024032600174370400_bib1","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/sj.ijir.3900567","article-title":"The worldwide prevalence and epidemiology of erectile dysfunction","volume":"12","author":"McKinlay","year":"2000","journal-title":"Int J Impot Res"},{"key":"2024032600174370400_bib2","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1038\/sj.ijir.3900487","article-title":"The epidemiology of erectile dysfunction: Results from the National Health and Social Life Survey","volume":"11","author":"Laumann","year":"1999","journal-title":"Int J Impot Res"},{"key":"2024032600174370400_bib3","first-page":"S21","article-title":"Quality of life assessment in sexual dysfunction trials","volume":"10","author":"Rosen","year":"1998","journal-title":"Int J Impot Res"},{"key":"2024032600174370400_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"2024032600174370400_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5694\/j.1326-5377.1999.tb123691.x","article-title":"Erectile dysfunction in the community: A prevalence study","volume":"171","author":"Pinnock","year":"1999","journal-title":"Med J Aust"},{"key":"2024032600174370400_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/fampra\/15.6.519","article-title":"Sexual problems: A study of the prevalence and need for health care in the general population","volume":"15","author":"Dunn","year":"1998","journal-title":"Fam Pract"},{"key":"2024032600174370400_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.ijir.3900457","article-title":"Erectile dysfunction in general medicine practice: Prevalence and clinical correlates","volume":"12","author":"Chew","year":"2000","journal-title":"Int J Impot Res"},{"key":"2024032600174370400_bib8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0094-0143(21)00690-X","article-title":"The epidemiology of erectile dysfunction","volume":"22","author":"Benet","year":"1995","journal-title":"Urol Clin North Am"},{"key":"2024032600174370400_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(85)92023-9","article-title":"Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men","volume":"1","author":"Virag","year":"1985","journal-title":"Lancet"},{"key":"2024032600174370400_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0895-7061(98)00225-8","article-title":"The prevalence and etiology of impotence in 101 male hypertensive outpatients","volume":"12","author":"Jensen","year":"1999","journal-title":"Am J Hypertens"},{"key":"2024032600174370400_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jacc.2003.07.042","article-title":"Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease","volume":"43","author":"Kaiser","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2024032600174370400_bib12","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group","volume":"338","author":"Goldstein","year":"1998","journal-title":"N Engl J Med"},{"key":"2024032600174370400_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-5347(17)37759-5","article-title":"Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle","volume":"146","author":"Azadzoi","year":"1991","journal-title":"J Urol"},{"key":"2024032600174370400_bib14","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0022-5347(17)37676-0","article-title":"Erectile dysfunction due to atherosclerotic vascular disease: The development of an animal model","volume":"147","author":"Azadzoi","year":"1992","journal-title":"J Urol"},{"key":"2024032600174370400_bib15","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJM198904203201601","article-title":"Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence","volume":"320","author":"Saenz de Tejada","year":"1989","journal-title":"N Engl J Med"},{"key":"2024032600174370400_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s003450000168","article-title":"Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: A RigiScan and pharmacokinetic study","volume":"19","author":"Klotz","year":"2001","journal-title":"World J Urol"},{"key":"2024032600174370400_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/sj.ijir.3900713","article-title":"The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: The first at-home clinical trial","volume":"13","author":"Porst","year":"2001","journal-title":"Int J Impot Res"},{"key":"2024032600174370400_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1368-5031.2004.00128.x","article-title":"Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction","volume":"58","author":"Stief","year":"2004","journal-title":"Int J Clin Pract"},{"key":"2024032600174370400_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/j.1939-4640.2002.tb02332.x","article-title":"Vardenafil for treatment of men with erectile dysfunction: Efficacy and safety in a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Hellstrom","year":"2002","journal-title":"J Androl"},{"key":"2024032600174370400_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/diacare.26.3.777","article-title":"Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: A multicenter double-blind placebo-controlled fixed-dose study","volume":"26","author":"Goldstein","year":"2003","journal-title":"Diabetes Care"},{"key":"2024032600174370400_bib21","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/01.ju.0000086947.00547.49","article-title":"Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy","volume":"170","author":"Brock","year":"2003","journal-title":"J Urol"},{"key":"2024032600174370400_bib22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1464-410X.2004.05161.x","article-title":"Erectile response with vardenafil in sildenafil nonresponders: A multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial","volume":"94","author":"Carson","year":"2004","journal-title":"BJU Int"},{"key":"2024032600174370400_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.eururo.2004.03.011","article-title":"Efficacy of vardenafil in men with erectile dysfunction: A flexible-dose community practice study","volume":"46","author":"Potempa","year":"2004","journal-title":"Eur Urol"},{"key":"2024032600174370400_bib24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1743-6109.2005.00138.x","article-title":"Flexible-dose vardenafil in a community-based population of men affected by erectile dysfunction: A 12-week open-label, multicenter trial","volume":"2","author":"Mirone","year":"2005","journal-title":"J Sex Med"},{"key":"2024032600174370400_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1743-6109.2005.20111.x","article-title":"Vardenafil improves satisfaction rates, depressive symptomatology, and self-confidence in a broad population of men with erectile dysfunction","volume":"2","author":"Hatzichristou","year":"2005","journal-title":"J Sex Med"},{"key":"2024032600174370400_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1743-6109.2005.00119.x","article-title":"Improving the sexual quality of life of couples affected by erectile dysfunction: A double-blind, randomized, placebo-controlled trial of vardenafil","volume":"2","author":"Fisher","year":"2005","journal-title":"J Sex Med"},{"key":"2024032600174370400_bib27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1743-6109.2005.00147.x","article-title":"Women\u2019s sexual function improves when partners are administered vardenafil for erectile dysfunction: A prospective, randomized, double-blind, placebo-controlled trial","volume":"2","author":"Goldstein","year":"2005","journal-title":"J Sex Med"},{"key":"2024032600174370400_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1742-1241.2005.00451.x","article-title":"A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: A randomised, double-blind, parallel-group, placebo-controlled study in Australian men","volume":"59","author":"McMahon","year":"2005","journal-title":"Int J Clin Pract"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951531403X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951531403X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/3\/5\/892\/47737622\/jsm_3_5_892.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/3\/5\/892\/47737622\/jsm_3_5_892.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:11:45Z","timestamp":1711415505000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/3\/5\/892\/6883174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,9,1]]},"published-print":{"date-parts":[[2006,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2006.00296.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"type":"electronic","value":"1743-6109"},{"type":"print","value":"1743-6095"}],"subject":[],"published-other":{"date-parts":[[2006,9]]},"published":{"date-parts":[[2006,9,1]]}}}